Ionctura CEO Presents at 2026 J.P. Morgan Healthcare Conference
09 Jan 2026 //
PR NEWSWIRE
IOnctura Launches Phase I/II Myelofibrosis Trial Pre-ASH
04 Dec 2025 //
PR NEWSWIRE
iOnctura Advances Roginolisib Trials in US, Expands Oncology
09 Sep 2025 //
PR NEWSWIRE
iOnctura commences Phase I/II study in non-small cell lung cancer
08 May 2025 //
PR NEWSWIRE
iOnctura starts Phase II study in metastatic uveal melanoma
20 Mar 2025 //
PR NEWSWIRE
iOnctura announces expansion of roginolisib clinical trial program to NSCLC
09 Jul 2024 //
PR NEWSWIRE

Market Place
Sourcing Support